TELA Bio (TELA) Operating Margin (2018 - 2026)
TELA Bio (TELA) posted Operating Margin of 48.12% for Q2 2026, up 12.87% on a QoQ basis from 55.23% in Q1 2026, and down 316.0% year-over-year from 22.28% in Q2 2025.
Powered by 
Analysis
TELA Bio (TELA) Operating Margin (2018 - 2026) Analysis & Trends
TELA Bio has reported Operating Margin for 9 years, with the latest figure at 48.12% in Q2 2026.
- On a quarterly basis, Operating Margin fell 316.0% year-over-year to 48.12% in Q2 2026; TTM through Jun 2026 was 42.56%, a 692.0% increase from a year earlier, with the FY2025 full-year figure at 42.05%, up 718.0% from the prior year.
- Operating Margin was 48.12% for Q2 2026 at TELA Bio, up from 55.23% in the prior quarter.
- The five-year high for Operating Margin was 29.07% in Q1 2024, with the low at 119.6% in Q1 2022.
- Average Operating Margin over 5 years is 64.5%, with a median of 62.09% recorded in 2023.
- The sharpest annual moves came in 2024 and 2025: Operating Margin soared 6543 bps in 2024, then slumped 2748 bps in 2025.
- Over 5 years, Operating Margin stood at 81.22% in 2022, then rose by 11 bps to 72.23% in 2023, then soared by 34 bps to 47.33% in 2024, then soared by 33 bps to 31.86% in 2025, then slumped by 51 bps to 48.12% in 2026.
- The last three Operating Margin figures came in at 48.12% (Q2 2026), 55.23% (Q1 2026), and 31.86% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.53 Bn | 174.93 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 127.82 Bn | 122.60 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 117.07 Bn | 108.25 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 104.13 Bn | 100.65 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 49.72 Bn | 45.47 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 33.00 Bn | 31.55 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 32.13 Bn | 30.18 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 19.15% |
| 10 | TELA Bio | 50.51 Mn | 20.09 Mn | 13.94 Mn | -48.12% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -48.12% |
| Mar 31, 2026 | -55.23% |
| Dec 31, 2025 | -31.86% |
| Sep 30, 2025 | -36.51% |
| Jun 30, 2025 | -44.96% |
| Mar 31, 2025 | -56.54% |
| Dec 31, 2024 | -47.33% |
| Sep 30, 2024 | -49.40% |
| Jun 30, 2024 | -71.90% |
| Mar 31, 2024 | -29.07% |
| Dec 31, 2023 | -72.23% |
| Sep 30, 2023 | -67.64% |
| Jun 30, 2023 | -71.49% |
| Mar 31, 2023 | -94.50% |
| Dec 31, 2022 | -81.22% |
| Sep 30, 2022 | -85.02% |
| Jun 30, 2022 | -98.38% |
| Mar 31, 2022 | -119.60% |
| Dec 31, 2021 | -91.40% |
| Sep 30, 2021 | -94.29% |